In addition, flow cytometry showed that Mabc-mediated iNOS protein expression was significantly amplified in OMS-treated BMDMs compared to untreated controls (Figure 6(b)). This evidence concerns the gene NOS2 and opsoclonus-myoclonus syndrome.